Article Details
Retrieved on: 2024-08-24 08:39:05
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the IPO plans of Zenas BioPharma and Bicara Therapeutics in the biopharma sector, highlighting their backing by major investors and clinical data. Notable biopharma entities and figures, such as Bristol-Myers Squibb, Biocon, and Kiran Mazumdar-Shaw, are also mentioned.
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here